Viewing Study NCT03531918


Ignite Creation Date: 2025-12-25 @ 4:57 AM
Ignite Modification Date: 2025-12-26 @ 3:57 AM
Study NCT ID: NCT03531918
Status: COMPLETED
Last Update Posted: 2023-08-30
First Post: 2018-05-09
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm
Sponsor: Fred Hutchinson Cancer Center
Organization: